Brandon Weiss

My team and I are still seeking volunteers for our 10-minute survey study about psychedelic experiences among veterans. If you are a veteran, we are interested in your experiences, especially with psilocybin and MDMA. To participate, visit: hopkinspsychedelic.org/veteransurvey Best wishes

UCSF’s Translational Psychedelic Research Program has made history by proving that psilocybin is not only safe in Parkinson’s patients, but there were significantly improved mood symptoms, and the most delightfully surprising result is that motor symptoms also improved! 🧵

NEW: Oregon Psilocybin Services Tracker As the first cut of data from Oregon’s psilocybin program becomes available, we publish our first Oregon Psilocybin Services Tracker, which takes a deep dive into emerging trends through data viz & analysis. psychedelicalpha.com/news/oregon-ps…

Recently I’ve been seeing evidence of public support for research on psychedelic therapies at the highest levels of HHS, VA, and Congress. Surreal but v heartening to see this coalescing and inertia building. ✨🇺🇸

Grateful to provide education & perspective on psychedelic science to our nation’s policy leaders, with @BWe1ss, @ExistWell, @sdpnayak. Thank you to @RepLouCorrea and @RepJackBergman for your leadership and for inviting us to share our work with the PATH caucus! @JHPsychedelics

Public science education is core to our mission at @JHPsychedelics, so we went to DC to talk to congress. Pictured: @FredBarrettPhD & @BWe1ss brief the PATH caucus led by @RepLouCorrea @RepJackBergman on research on psilocybin for AUD & PTSD. (@sdpnayak present but not in pic).

The Psychedelic Assisted Therapy Caucus (PATH) looks to bring psychedelic therapies to cure invisible wounds veterans bring back from the battlefield.  At yesterday's PATH Caucus meeting, we hosted John Hopkins Medical School Doctors Barrett and Weiss, who presented their…

That’s a wrap on Psychedelic Science 2025! We had a fantastic time presenting our research and connecting with both new and familiar faces in the field. Grateful for the conversations, collaborations, and inspiration. Excited for what’s ahead! @PsychedelicSci @MAPS @BWe1ss…

Today is publication day for my book, Shamanism: The Timeless Religion. To celebrate, here are some of my striking clips of shamanic rituals that I came across while working on the book:

@sdpnayak @BWe1ss @CeydaSayali @NathalieRieser @SeanPGoldy @n_sepeda

🚨🍄 Major new preprint alert 🍄🚨 I think these will be important results. They are not going make me popular with my #psychedelic in-group, please do not shoot the messenger! The premise of this pre-registered meta analysis (osf.io/preprints/psya…) is that it is biased to…

A great step toward standardizing reporting of extrapharmacologic factors in psychedelic trials! Congrats @ChloePronovostM @LeorRoseman et al nature.com/articles/s4159…

At the recent Psychedelic Therapeutics and Drug Development Conference, Assistant Professor Dr. Brandon Weiss served on a key panel, "Industry-Academic Collaboration: The Path to Success." Alongside fellow experts Dr. Amber Burch from Purisys, Dr. Dan Perkins of the University of…

At Summit Behavioral Health's 'Tactical Recovery' Continuing Education event, Assistant Professor Dr. Brandon Weiss (@BWe1ss) spoke to 150 clinicians about the ethical administration, risks, and benefits of psychedelic therapies. This session was specifically designed for mental…

Dr. John Krystal of #yalepsych and @YaleMed spoke to @HopkinsPsych about Lessons from ketamine: informing treatments for schizophrenia, depression, and PTSD. Event organized by CPCR Faculty Brandon Weiss @BWe1ss

CPCR is hiring a postdoc to manage the operation of clinical drug trials focused on the treatment of PTSD with psychedelic therapy. Read more below!

Dr. Brandon Weiss (@BWe1ss), Assistant Professor, contributed to a thoughtful and compassionate perspective to the "Military Voices" panel at last week's Federal Summit on Psychedelic Medicine, alongside Veterans Jay Kopelman, Dr. Leith States, and Rear Admiral (Ret.) Dr. James…